SAN FRANCISCO, Oct. 17 – Applied Biosytems and SurroMed jointly received a three-year $8 million grant from the National Institute of Standards and Technology Advanced Technology Program, the companies announced Wednesday.

The grant is for the development of Mountain View, Calif.-based SurroMed's nanoscale technology and Foster City, Calif.-based Applied Biosystems' multiplexing chemistry capabilities for DNA analysis. $3.7 million is slated for SurroMed and $4.3 million for Applied Biosystems, according to the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.